Table 1a.

Analyzed seroconversion of trivalent sIPV with different dose and adjuvanted group after the first immunization.

	Type I				Type II				Type III
Groups	R(%)	P1	P2		R(%)	P1	P2		R(%)	P1	P2
Full-dose sIPV	100	—	0.001		50	—	0.001		60	—	NS
1/4-dose sIPV	20	0.001	—		0	0.001	—		20	NS	—
1/4-dose+AS03	100	NS	0.001		100	NS	0.000		100	0.011	0.001
1/4-dose+BW006	100	NS	0.001		50	NS	0.033		60	NS	NS
1/4-dose+Poly:IC	70	NS	NS		0	0.001	NS		0	NS	NS
1/4 dose+AS03+ BW006	100	NS	0.001		100	NS	0.000		100	0.011	0.001
Total		P = 0.011				P = 0.000				P = 0.000

Note: Seroconversion refers to a reciprocal antibody titer of 8 or higher. Data are proportion(%) of subjects with seroconversion(n = 10).

p1 values are compared with the full-dose group, p2 values are compared with the 1/4-dose group. NS denotes not significant.